Veracyte Inc (VCYT)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $1.94B
Last updated: Nov 17, 2026 at 5:47 PM ET
Veracyte Inc (VCYT) Stock Chart
Veracyte (VCYT) has a latest price of $24.23 on Nov 17, 2026, 60.2% below its 52-week high of $60.91. Its price fell 38.4% over the past 12 months. The month-end price rose 588.8% over the 10 years through Oct 2026, a compound annual rate of 21.3%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $58.73 in Jun 2026 and its lowest $5.56 in Mar 2018, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart VCYT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for VCYT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 42.6%, and over 6 months it fell 41.9%. The month-end price rose 141.4% over the 3 years through Oct 2026, a compound annual rate of 34.1%.
| Period | Change |
|---|---|
| 1 month | -44.7% |
| 3 months | -42.6% |
| 6 months | -41.9% |
| 12 months | -38.4% |
| 12 months, with dividends | -38.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +141.4% | +34.1% |
| 5 years | +4.4% | +0.9% |
| 10 years | +588.8% | +21.3% |
Price by Year
Its best calendar year was 2019, when the price rose 121.9%, and its weakest was 2022, when it fell 42.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $50.01 | +18.8% |
| 2025 | $42.10 | +6.3% |
| 2024 | $39.60 | +43.9% |
| 2023 | $27.51 | +15.9% |
| 2022 | $23.73 | -42.4% |
| 2021 | $41.20 | -15.8% |
| 2020 | $48.94 | +75.3% |
| 2019 | $27.92 | +121.9% |
| 2018 | $12.58 | +92.6% |
| 2017 | $6.53 | -15.6% |
Trading Range
The price is 41.5% below its 50-day average of $41.43 and 42.6% below its 200-day average of $42.24.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $24.23 | |
| 52-week high | $60.91 | -60.2% |
| 52-week low | $21.91 | +10.6% |
| 50-day average | $41.43 | -41.5% |
| 200-day average | $42.24 | -42.6% |
Price Risk
Over 3 years, its largest fall from a peak was 60.3%.
| Measure | Value |
|---|---|
| 1-year beta | 3.19 |
| Largest fall, 1 year | -60.3% |
| Largest fall, 3 years | -60.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About VCYT
What is VCYT's 1-year price change?
Veracyte's price fell 38.4% over the past 12 months. With dividends included, the 12-month total return was -38.4%.
What is VCYT's 5-year price change?
Veracyte's month-end price rose 4.4% over the 5 years through Oct 2026, a compound annual rate of 0.9%. These figures leave out dividends.
What is VCYT's 52-week high and low?
Veracyte's 52-week high is $60.91 and its 52-week low is $21.91. Its latest price of $24.23 on Nov 17, 2026 is 60.2% below the high.
What is VCYT's beta?
Veracyte's 1-year beta against the S&P 500 is 3.19, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 60.3%.
Is the VCYT chart free?
Yes. Advanced Charting for VCYT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
VCYT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts